CHILDHOOD CANCER DATA INITIATIVE: CLINICAL TRIAL SPECIMEN MOLECULAR CHARACTERIZATION (CTSMC) PROGRAM

Abstract

The Clinical Trial Specimen Molecular Characterization (CTSMC) initiative will further the CCDI’s goals by providing molecular characterization of specimens from pediatric and AYA patients enrolled to NCI-funded clinical trials conducted by the PBTC, PEP-CTN, Pediatric CITN, and Children’s Oncology Group for use in the conduct of the trials and related correlative science studies.

Key facts

NIH application ID

10281333

Project number

75N91019D00024-0-759102000021-1

Recipient

LEIDOS BIOMEDICAL RESEARCH, INC.

Principal Investigator

ETHAN DMITROVSKY

Activity code

N01

Funding institute

NIH

Fiscal year

2020

Award amount

$3,997,467

Award type

—

Project period

2020-09-25 → 2025-09-24